Last Posted: Oct 24, 2019
- Cost-effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome Cases.
Peterse Elisabeth F P et al. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019 Oct - Clinical Application of Next-Generation Sequencing as A Liquid Biopsy Technique in Advanced Colorectal Cancer: A Trick or A Treat?
Kastrisiou Myrto et al. Cancers 2019 Oct 11(10) - Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer.
Evrard Camille et al. Cancers 2019 Oct 11(10) - Patients in Whom to Consider Genetic Evaluation and Testing for Hereditary Colorectal Cancer Syndromes.
Kupfer Sonia S et al. The American journal of gastroenterology 2019 Oct - Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer.
López-Cortés Andrés et al. The pharmacogenomics journal 2019 Oct - Precision Treatment and Prevention of Colorectal Cancer-Hope or Hype?
Muller Charles et al. Gastroenterology 2019 Oct - Precision treatment in colorectal cancer: Now and the future.
Yau Tung On et al. JGH open : an open access journal of gastroenterology and hepatology 2019 Oct 3(5) 361-369 - The Colorectal Cancer Risk Assessment Tool
NCI, 2019 - Cost-effectiveness of risk-stratified colorectal cancer screening based on polygenic risk – current status and future potential
SK Naber et al, JNCI SPectrum, October 17, 2019 - Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Tie Jeanne, et al. JAMA oncology 2019 10 0.
.png)
No hay comentarios:
Publicar un comentario